Author Archives: Jean-Michel Pawlotsky

Hepatitis C Drugs: Is Next-Generation the Last-Generation?

Posted on August 30, 2016 by Jean-Michel Pawlotsky
Posted in News | Comments Off on Hepatitis C Drugs: Is Next-Generation the Last-Generation?

Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens

Posted on April 11, 2016 by Jean-Michel Pawlotsky

Treatment of hepatitis C virus (HCV) infection has progressed considerably with the approval of interferon-free, direct-acting antiviral (DAA)-based combination therapies. Although most treated patients achieve virological cure, HCV resistance to DAAs … Continue reading →

Posted in News | Comments Off on Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens